IRON Disc Medicine RESULTS: Q2, Q2 basic EPS $-1.54 vs. EST $-1.75, Q2 operating expenses $65.075M, Q2 Operating Income $-65.075M vs. EST $
IRON Disc Medicine RESULTS: Q2, Q2 basic EPS $-1.54 vs. EST $-1.75, Q2 operating expenses $65.075M, Q2 Operating Income $-65.075M vs. EST $-71M, Q2 Net Income $-59.532M vs. EST $-68.2M